China Pharma Holdings Inc. is a Nevada holding company that operates Hainan Helpson Medical and Biotechnology, a Chinese pharmaceutical manufacturer focused on developing, manufacturing, and marketing drugs for high-incidence and high-mortality diseases prevalent in China. The company produces 19 pharmaceutical products across three categories—basic generic drugs, first-to-market generics, and modern Traditional Chinese Medicines—in multiple formulations including dry powder injectables, liquid injectables, tablets, and capsules, all approved by China's National Medical Products Administration. Helpson operates two GMP-certified production facilities in Haikou and distributes its products to hospitals and pharmacies through a national sales network, generating revenue from three primary therapeutic areas: central nervous system and cardiovascular disease treatments, anti-viral and respiratory medications, and digestive disease drugs.